World News: 12:00 GMT Thursday 6th December 2018. [Axovant Sciences Ltd. via Globe Newswire via SPi World News]
BASEL Switzerland Dec 06 2018 GLOBE NEWSWIRE -- Axovant Sciences NASDAQ AXON a clinical-stage company developing innovative gene therapies for neurological conditions today announced feedback from a face-to-face pre-IND meeting with the U.S. F...
Globe Newswire: 12:00 GMT Thursday 6th December 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.